Status:
COMPLETED
Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma
Lead Sponsor:
Samsung Medical Center
Conditions:
Thyroid Cancer
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to determine whether the prophylactic ipsilateral central lymph node dissection is equally effective in the management of papillary thyroid microcarcinoma(PTMC) to the bil...
Detailed Description
The extent, the advantage and disadvantage of prophylactic central lymph node dissection was not fully established up to now in papillary thyroid microcarcinoma. Prophylactic bilateral central lymph ...
Eligibility Criteria
Inclusion
- Age: 18 to 70
- Sonographically node-negative cytology confirmed thyroid papillary carcinoma
- Tumor size less than 1 cm in sonography
- Tumor confined to the one lobe of the thyroid gland
- One who provides the informed consent
Exclusion
- History of radiation treatment to head and neck area
- History of other malignancy except thyroid cancer
- Poor performance status (ECOG 3-4)
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
258 Patients enrolled
Trial Details
Trial ID
NCT00795782
Start Date
January 1 2009
End Date
June 1 2014
Last Update
April 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710